Opko Health Inc. (NASDAQ:OPK) announces that GeneDx, a business unit of OPKO’s BioReference Laboratories division, will be showcasing its leadership in genetic and …
Looking for a reason to buy shares of Opko Health Inc. (NASDAQ:OPK)?
Opko Health Inc. (NASDAQ:OPK) announced that the Kidney Disease Improving Global Outcomes (KDIGO) organization has updated its Clinical Practice Guideline for the Diagnosis, …
Opko Health Inc. (NASDAQ:OPK) announces an update to the topline data analysis of the Phase 3, double-blind, placebo-controlled study of its investigational long-acting …
Opko Health Inc. (NASDAQ:OPK) announces it has entered into agreements with several large Medicare Part D plan sponsors, including the largest Medicare Part …
Opko Health Inc. (NASDAQ:OPK) reports operating and financial results for the three months ended March 31, 2017.
Opko Health Inc. (NASDAQ:OPK) announces that the Company has received orphan drug designation from the U.
In a research report released today, Guggenheim analyst Louise Chen initiated coverage on shares of Opko Health Inc. (NASDAQ:OPK) with a Buy rating and price target …
ParkerVision, Inc. (NASDAQ:PRKR) shares are soaring by 15% to $2.
Opko Health Inc. (NASDAQ:OPK) announced the appointment of Akhtar Ashfaq, MD, FACP, FASN to the position of Senior Vice President, Clinical Research and …
